🇺🇸 Panax Ginseng in United States

393 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 393

Most-reported reactions

1. Off Label Use — 47 reports (11.96%)
2. Somnolence — 44 reports (11.2%)
3. Condition Aggravated — 43 reports (10.94%)
4. General Physical Health Deterioration — 38 reports (9.67%)
5. Multiple Organ Dysfunction Syndrome — 38 reports (9.67%)
6. Sepsis — 38 reports (9.67%)
7. Stress — 38 reports (9.67%)
8. Hyponatraemia — 37 reports (9.41%)
9. Anaemia — 35 reports (8.91%)
10. Vomiting — 35 reports (8.91%)

Source database →

Frequently asked questions

Is Panax Ginseng approved in United States?

Panax Ginseng does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Panax Ginseng in United States?

Seoul National University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.